Return to study ST003053 main page

MB Sample ID: SA331537

Local Sample ID:T_1h_2
Subject ID:SU003168
Subject Type:Bacteria
Subject Species:Staphylococcus aureus
Taxonomy ID:1280
Genotype Strain:ATCC 43300
Age Or Age Range:NA
Weight Or Weight Range:NA
Height Or Height Range:NA
Gender:Not applicable

Select appropriate tab below to view additional metadata details:


Treatment:

Treatment ID:TR003177
Treatment Summary:An untargeted metabolomics study was carried out to explore the mechanism(s) of action of C12-o-(BG-D)-10 against MRSA ATCC 43300 using a concentration of 48 µg/mL (i.e. 3×MIC). Samples were taken and analyzed at the 1-, 3-, and 6-h time points in 4 biological replicates. An overnight culture was prepared by inoculating a single colony into 100 mL CAMHB in 250 mL conical flasks (Pyrex) and incubating the suspension in a shaker at 37°C and 180 rpm for ~16 h. After incubation overnight, log-phase cells were prepared in fresh MHB and then incubated for 2 h at 37°C at 180 rpm to log phase with a starting bacterial inoculum of 108 CFU/mL. Then, C12-o-(BG-D)-10 was added to obtain the desired concentration of 48 µg/mL (3 x MIC), in parallel to a CLO-free control for each replicate. The flasks were then incubated at 37°C with shaking at 180 rpm. At each time point (0, 1, 3, and 6 h), 15-mL samples were transferred to 50-mL Falcon tubes for quenching, and the optical density reading at 600 nm (OD600) was then measured and normalized to the pre-treatment level of approximately ~0.5 with fresh CAMHB. Samples were then centrifuged at 3,220 g and 4°C for 10 min, and the supernatants were removed. The pellets were stored at -80°C until metabolite extraction. The experiment was performed in 4 biological replicates to reduce the bias from inherent random variation.
Treatment Dose:48 ug/ml
Cell Media:CAMHB
  logo